Free Trial
ASX:EMD

Emyria (EMD) Stock Price, News & Analysis

Emyria logo

About Emyria Stock (ASX:EMD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
471,333 shs
Average Volume
N/A
Market Capitalization
A$16.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emyria and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMD Stock News Headlines

Emyria Strengthens Position with Strategic Share Sale
The End of Elon Musk…?
While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the verge of its biggest breakthrough yet — a revolutionary form of “Manifested AI” that Forbes has called a multi-trillion-dollar opportunity, potentially sparking a 25,000% growth market and setting up what he believes could be the greatest corporate comeback in history.tc pixel
See More Headlines

EMD Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Emyria investors own include AGNC Investment (AGNC), Ashford Hospitality Trust (AHT), Allakos (ALLK), Alpine Summit Energy Partners (ALPS), Brookfield Infrastructure Partners (BIP), BioXcel Therapeutics (BTAI) and Carador Income Fund (CIF).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:EMD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$11.46 million
Net Margins
-520.07%
Pretax Margin
N/A
Return on Equity
-678.78%
Return on Assets
-26.71%

Debt

Debt-to-Equity Ratio
70.86
Current Ratio
0.86
Quick Ratio
2.69

Sales & Book Value

Annual Sales
A$2.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
6.67
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
415,390,000
Free Float
N/A
Market Cap
A$16.12 million
Optionable
Not Optionable
Beta
0.81
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:EMD) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners